OBJECTIVE: To determine the feasibility of a randomized controlled trial of the effect of a tai chi program on quality of life and exercise capacity in patients with COPD. METHODS: We randomized 10 patients with moderate to severe COPD to 12 weeks oftai chi plus usual care (n = 5) or usual care alone (n = 5). The tai chi training consisted of a 1-hour class, twice weekly, that emphasized gentle movement, relaxation, meditation, and breathing techniques. Exploratory outcomes included disease-specific symptoms and quality-of-life, exercise capacity, pulmonary function tests, mood, and self-efficacy. We also conducted qualitative interviews to capture patient narratives regarding their experience with tai chi. RESULTS: The patients were willing to be randomized. Among 4 of the 5 patients in the intervention group, adherence to the study protocol was excellent. The cohort's baseline mean ± SD age, percent-of-predicted FEV₁, and ratio of FEV₁ to forced vital capacity were 66 ± 6 y, 50 ± 12%, and 0.63 ± 0.14, respectively. At 12 weeks there was significant improvement in Chronic Respiratory Questionnaire score among the tai chi participants (1.4 ± 1.1), compared to the usual-care group (-0.1 ± 0.4) (P = .03). There were nonsignificant trends toward improvement in 6-min walk distance (55 ± 47 vs -13 ± 64 m, P = .09), Center for Epidemiologic Studies Depression Scale (-9.0 ± 9.1 vs -2.8 ± 4.3, P = .20), and University of California, San Diego Shortness of Breath score (-7.8 ± 3.5 vs -1.2 ± 11, P = .40). There were no significant changes in either group's peak oxygen uptake. CONCLUSIONS: A randomized controlled trial of tai chi is feasible in patients with moderate to severe COPD. Tai chi exercise as an adjunct to standard care warrants further investigation.
RCT Entities:
OBJECTIVE: To determine the feasibility of a randomized controlled trial of the effect of a tai chi program on quality of life and exercise capacity in patients with COPD. METHODS: We randomized 10 patients with moderate to severe COPD to 12 weeks of tai chi plus usual care (n = 5) or usual care alone (n = 5). The tai chi training consisted of a 1-hour class, twice weekly, that emphasized gentle movement, relaxation, meditation, and breathing techniques. Exploratory outcomes included disease-specific symptoms and quality-of-life, exercise capacity, pulmonary function tests, mood, and self-efficacy. We also conducted qualitative interviews to capture patient narratives regarding their experience with tai chi. RESULTS: The patients were willing to be randomized. Among 4 of the 5 patients in the intervention group, adherence to the study protocol was excellent. The cohort's baseline mean ± SD age, percent-of-predicted FEV₁, and ratio of FEV₁ to forced vital capacity were 66 ± 6 y, 50 ± 12%, and 0.63 ± 0.14, respectively. At 12 weeks there was significant improvement in Chronic Respiratory Questionnaire score among the tai chi participants (1.4 ± 1.1), compared to the usual-care group (-0.1 ± 0.4) (P = .03). There were nonsignificant trends toward improvement in 6-min walk distance (55 ± 47 vs -13 ± 64 m, P = .09), Center for Epidemiologic Studies Depression Scale (-9.0 ± 9.1 vs -2.8 ± 4.3, P = .20), and University of California, San Diego Shortness of Breath score (-7.8 ± 3.5 vs -1.2 ± 11, P = .40). There were no significant changes in either group's peak oxygen uptake. CONCLUSIONS: A randomized controlled trial of tai chi is feasible in patients with moderate to severe COPD. Tai chi exercise as an adjunct to standard care warrants further investigation.
Authors: Peter M Wayne; David E Krebs; Steven L Wolf; Kathleen M Gill-Body; Donna M Scarborough; Chris A McGibbon; Ted J Kaptchuk; Stephen W Parker Journal: Arch Phys Med Rehabil Date: 2004-01 Impact factor: 3.966
Authors: Gloria Y Yeh; Malissa J Wood; Beverly H Lorell; Lynne W Stevenson; David M Eisenberg; Peter M Wayne; Ary L Goldberger; Roger B Davis; Russell S Phillips Journal: Am J Med Date: 2004-10-15 Impact factor: 4.965
Authors: François Maltais; Jean Bourbeau; Stan Shapiro; Yves Lacasse; Hélène Perrault; Marc Baltzan; Paul Hernandez; Michel Rouleau; Marcel Julien; Simon Parenteau; Bruno Paradis; Robert D Levy; Pat Camp; Richard Lecours; Richard Audet; Brian Hutton; John R Penrod; Danielle Picard; Sarah Bernard Journal: Ann Intern Med Date: 2008-12-16 Impact factor: 25.391
Authors: Steven L Wolf; Richard W Sattin; Michael Kutner; Michael O'Grady; Arlene I Greenspan; Robert J Gregor Journal: J Am Geriatr Soc Date: 2003-12 Impact factor: 5.562
Authors: Marilyn L Moy; Peter M Wayne; Daniel Litrownik; Douglas Beach; Elizabeth S Klings; Roger B Davis; Gloria Y Yeh Journal: Contemp Clin Trials Date: 2015-09-08 Impact factor: 2.226
Authors: Peter M Wayne; Danielle L Berkowitz; Daniel E Litrownik; Julie E Buring; Gloria Y Yeh Journal: Arch Phys Med Rehabil Date: 2014-05-27 Impact factor: 3.966
Authors: Peter M Wayne; Margaret M Gagnon; Eric A Macklin; Thomas G Travison; Bradley Manor; Margie Lachman; Cindy P Thomas; Lewis A Lipsitz Journal: Contemp Clin Trials Date: 2017-07-08 Impact factor: 2.226
Authors: Jessica Aviles; Gwenndolyn C Porter; Paul A Estabrooks; Neil B Alexander; Michael L Madigan Journal: Transl J Am Coll Sports Med Date: 2020-03-15